July 25, 2007
For Immediate ReleaseMedical Technology Takes Turn Toward Hybrids, Increased Performance
FOOTHILL RANCH, CA --- If the types of technologies that are now under development at new medical technology startups are any indication, manufacturers are increasingly turning toward the addition of technologies that are complementary to devices in order to achieve gains in product performance.
"We are certainly seeing traditional, so to speak, medical technologies under development --- the development of novel devices that by virtue of their structure offer new clinical benefits," says Patrick Driscoll, President of MedMarket Diligence. "But more and more new products are being developed that integrate multiple different technologies to achieve outcomes demonstrating much better performance."
According to Driscoll, the obvious example of drug-eluting stents is only one of many examples in which traditional devices are coupled (physically or procedurally) with other technologies to produce results that "plain vanilla" devices simply cannot. Examples:
• antithrombogenic and antimicrobial coatings to enhance biocompatibility of devices
• devices made of materials safe for imaging under MRI
• drug-eluting devices in orthopedics, ophthalmology, urology and other clinical areas
• bioresorbable stents, shunts and other devices
• devices with nanoscale features or other designs
MedMarket Diligence introduced, in Q2, an online-accessed database of medical technology startup companies drawn from ongoing research for the companies MedMarkets publication and the company's Market and Technology Reports. A sampling of startups founded in the past 12 months (since mid-2006) shows the diversity of technologies under development and the frequent use of multiple technologies and other technology improvements to achieve superior results. Below are specific technologies under development by companies founded since mid-2006 and detailed in the MedMarket Diligence Medtech Startups Database:
The MedMarket Diligence Medtech Startups Database is described here. The database includes companies whose operations started typically no more than one year prior to their identification in research for MedMarket Diligence's MedMarkets and Report. Startups are included for several years in the database to track changes in development and other company details.
About MedMarket Diligence
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the MedMarkets newsletter, a monthly analysis of the market implications of new medical technologies, and dedicated Reports on technology markets. The company has also introduced the Medtech Startup Companies Database, a unique database of newly founded medical technology companies that can be accessed online (annual subscription available).
Contact: Patrick Driscoll, tel: +1-949-859-3401, patrick<at>mediligence<dot>com.